SCHEMBL13668397

SCHEMBL13668397

CC(C)(C)OC(=O)COc1ccc(NC(=O)OCc2ccccc2)cc1N

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TP53 P04637 2/20 0.49
MAPT P10636 2/20 0.49
MGLL Q99685 3/20 0.47
NPC1 O15118 1/20 0.46
ALDH1A1 P00352 1/20 0.46
TSHR P16473 1/20 0.46
RAB9A P51151 1/20 0.46
ATM Q13315 1/20 0.46
SMN1; SMN2 Q16637 1/20 0.46
POLB P06746 1/20 0.44
KDM1A O60341 2/20 0.43
MAOA P21397 2/20 0.43
MAOB P27338 2/20 0.43
ENPP2 Q13822 2/20 0.43
ROCK2 O75116 1/20 0.43
TDP1 Q9NUW8 1/20 0.43
RCOR1 Q9UKL0 1/20 0.43
BLK P51451 1/20 0.42
BTK Q06187 1/20 0.42
LTA4H P09960 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13665139 0.85 MGLL (0.45) TP53MAPTMGLLNPC1ALDH1A1
SCHEMBL8770370 0.82 TP53 (0.68) TP53MAPTNPC1ALDH1A1RAB9A
SCHEMBL11694836 0.81 TP53 (0.57) TP53MAPTMGLLNPC1ALDH1A1
SCHEMBL13668396 0.78 MAPT (0.38) MAPTALDH1A1POLB
SCHEMBL394888 0.78 MGLL (0.55) TP53MAPTMGLLNPC1ALDH1A1
SCHEMBL7043026 0.77 POLB (0.62) TP53MAPTMGLLNPC1ALDH1A1
SCHEMBL12325529 0.76 MGLL (0.59) TP53MAPTMGLLNPC1ALDH1A1
SCHEMBL7292267 0.76 SMPD1 (0.47) MAPTNPC1ALDH1A1RAB9ASMN1; SMN2
SCHEMBL21999646 0.75 ACLY (0.53) MAPTNPC1ALDH1A1POLBHDAC3
SCHEMBL24915804 0.75 SYK (0.51) TP53MAPTNPC1ALDH1A1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7605158-B2 Carbamoyl-type benzofuran derivatives MITSUBISHI TANABE PHARMA CORPORATION (JP) 2009-10-20 US disclosed
US-20090209511-A1 Benzofuran Derivatives KAWAGUCHI TAKAYUKI 2009-08-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090209511-A1 Benzofuran Derivatives F12, F2, F3 TP53 4644/4885MAPT 4681/4885MGLL 4721/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.